Pityriasis alba

L12_PITYR_ALBA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L30.5 Hospital discharge: ICD-9 — 6965 Hospital discharge: ICD-8 — 6965 Cause of death: ICD-10 — L30.5 Cause of death: ICD-9 — 6965 Cause of death: ICD-8 — 6965 2 out of 7 registries used, show all original rules.	33
4. Check minimum number of events None	33
5. Include endpoints None	33
6. Filter based on genotype QC (FinnGen only)	33

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L30
Name in latin: Pityriasis alba

NAME	L12_PITYR_ALBA
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L305
HD_ICD_9	6965
HD_ICD_8	6965
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L305
COD_ICD_9	6965
COD_ICD_8	6965
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pityriasis alba based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	318	173	144
Only index persons	272	151	121
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.01	0.01	0.00
Median age at first event (years)
Whole population	27.12	35.53	16.60
Only index persons	29.63	37.19	20.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	33	21	12
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	47.33	53.12	37.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

3.48

2.21

1.9

1.3

—

(3000494) Fungus identified in Specimen by Culture

3.25

2.06

1.4

1.6

—

(3042936) Bacteria identified in Isolate by Culture

3.05

1.92

2.2

2.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

193

2.63

1.60

3.7

4.2

13.3

11.6

mm/h

0.26

176

(4010399)

3.08

1.33

1.6

1.4

—

(36304419) Bacteria [Presence] in Urine

2.17

1.21

3.3

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

2.07

1.08

3.1

2.9

13.5

19.5

e6/l

—

(3002256) Pathology report gross observation

0.00

1.03

0.0

1.2

—

(4035726)

0.00

1.03

0.0

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

154

2.00

1.03

9.7

12.6

5.0

3.8

e9/l

0.84

133

(3018095) Leukocytes [#/volume] in Urine

1.97

1.02

3.3

3.1

468.2

76.8

e6/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.06

0.86

1.8

2.4

3.5

9.1

umol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

112

1.83

0.85

2.1

1.7

94.7

99.1

pmol/l

—

(40758558) Short blood count panel - Blood

1.86

0.77

4.1

10.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

209

1.81

0.74

4.3

4.1

14.3

15.1

pmol/l

0.83

190

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1.73

0.69

3.6

2.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

243

2.00

0.68

27.2

14.5

38.8

41.2

0.50

187

(3033658) Prothrombin time (PT) actual/Normal

1.81

0.68

3.0

2.8

90.0

95.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.93

0.63

16.7

8.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.00

0.62

0.0

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.62

0.0

1.5

—

(3000991) Gas panel - Venous blood

0.00

0.62

0.0

4.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.00

0.62

0.0

1.3

—

(3023368) Bacteria identified in Blood by Culture

1.59

0.59

5.1

4.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1.64

0.52

1.3

2.1

1.4

mmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.53

0.44

5.4

3.7

—

(3013512) EKG study

1.44

0.43

4.7

4.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

178

1.49

0.42

3.3

4.4

—

(3021589) Normoblasts [#/volume] in Blood

110

1.47

0.41

6.8

9.4

0.0

e9/l

—

(40768804) Tissue Pathology biopsy report

103

1.43

0.35

1.7

1.8

—

(3026008) Bacteria identified in Urine by Culture

1.48

0.35

4.2

2.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

251

1.42

0.28

6.7

3.7

1.8

1.3

mmol/l

2.10

229

(1761868) Lipid panel - Serum or Plasma

100

0.74

0.26

2.5

3.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.22

0.0

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.22

0.0

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.22

0.0

2.0

—

(40768793) Breast Pathology biopsy report

0.00

0.22

0.0

1.5

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.22

0.0

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.22

0.0

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.22

0.0

3.3

—

85.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.22

0.0

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

3.0

—

0.2

—

(4094501)

0.00

0.22

0.0

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

36.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3000330) Specific gravity of Urine by Test strip

0.00

0.21

0.0

4.7

—

(3008898) HLA-B27 [Presence]

0.00

0.20

0.0

1.2

—

(3015736) pH of Urine

103

1.26

0.17

4.5

3.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.16

0.10

1.4

1.2

—

(42870588) Differential panel, method unspecified - Blood

1.13

0.08

9.0

6.0

—

(3044640) Blood type and Crossmatch panel - Blood

1.12

0.08

4.0

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

120

1.14

0.06

7.1

3.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

163

1.09

0.02

3.4

2.7

—

(3044889) 12 lead EKG panel

185

1.06

0.00

4.2

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1.06

0.00

6.8

4.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

111

0.99

0.00

8.2

4.4

36.8

36.7

g/l

0.02

104

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.0

1.4

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.0

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.8

—

(44790048)

0.00

0.0

2.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

3.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

4.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.0

1.3

—

95.5

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.8

—

(44790049)

0.00

0.0

2.7

—

(44806118)

0.00

0.0

2.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.8

—

(44790047)

0.00

0.0

2.7

—

(4034850)

0.00

0.0

8.8

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1.00

0.00

2.1

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.0

2.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.94

0.00

4.3

3.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.2

—

109.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.7

—

187.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

9.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

0.00

0.0

4.4

—

12.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

4.2

—

34.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

0.92

0.00

1.5

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

0.0

1.9

—

4.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.04

0.00

3.3

3.7

0.7

1.9

ug/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

0.00

0.0

3.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4306422)

0.00

0.0

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.89

0.00

11.8

5.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

276

1.10

0.00

23.8

13.7

4.0

3.9

mmol/l

0.36

264

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

5.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

275

1.12

0.00

23.5

13.6

139.8

140.0

mmol/l

0.31

264

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PITYR_ALBA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_PITYR_ALBA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_PITYR_ALBA – Pityriasis alba

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pityriasis alba

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints